FOR IMMEDIATE RELEASE
INSURICA Announces 4th Quarter Acquisition Activity
OKLAHOMA CITY, OKLAHOMA (December 27, 2018)
– INSURICA, the 23rd largest privately-owned insurance agency in the U.S., released details of its fourth quarter agency acquisitions.
Known for a methodical and strategic approach to acquisitions, INSURICA focused their late-2018 activities on enhancing the agency’s small business division and two metroplex locations.
Fourth quarter acquisitions include:
- Commercial Insurance.net, Norman, OK (October 25, 2018) – already a partner in the online lead generation and small business agency, INSURICA purchased the insurance operations and will merge clients into their successful online small business platform, INSURICA Express.
Deal effective date: 11-01-2018.
- McNeil and Company, Arlington, TX (November 14, 2018) – Gary McNeil and his account team will join INSURICA’s Arlington office.
Deal effective date: 01-01-2019.
- Glen Tolentino, Oklahoma City, OK (November 16, 2018) – Glen Tolentino will join the Construction Practice of INSURICA’s Oklahoma City office.
Deal effective date: 01-01-2019.
About INSURICA:
With over $100M in annual revenue, INSURICA is among the largest insurance brokers in the United States. INSURICA has 30 offices located throughout Oklahoma, Texas, Arkansas, Arizona, and California.
FOR MORE INFORMATION:
Kevin Wellfare, VP Marketing
405.523.2100
Kevin.Wellfare@INSURICA.com
About the Author
Share This Story
Related Blogs
RxDC Reporting: What Employers Should Do Before the June 1 Deadline
Each year, group health plans must report detailed prescription drug and healthcare spending data to the Centers for Medicare & Medicaid Services (CMS). This reporting—commonly referred to as RxDC reporting—is due by June 1 and applies to most employer-sponsored group health plans that offer prescription drug coverage.
Chronic Condition Management 2.0: GLP-1 Alternatives and New Digital Therapeutics
Chronic conditions have long been the primary driver of employer healthcare spending, but 2026 marks a turning point in how organizations are approaching prevention, treatment, and long-term management. With GLP-1 medications dominating headlines — and budgets — employers are urgently exploring complementary or alternative strategies that can improve outcomes without unsustainable cost growth. The result is a new wave of digital therapeutics, metabolic health programs, and integrated care models that promise a more balanced approach to chronic disease management.
The Return-to-Office Reset: How Benefits Are Being Re-Engineered in 2026
After several years of experimentation, many employers are tightening hybrid schedules or requiring more in-office days. This “return-to-office reset” is reshaping benefits strategies as organizations look for ways to support commuting employees, improve onsite experience, and maintain flexibility. What began as a workplace policy shift is now driving a broader rethinking of how benefits can reinforce culture, productivity, and retention.